HRS-2189
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for HRS-2189, covering 2024-12-18 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients [Phase 1, Phase 2]